User Consideration
Team has made an effort to consider the needs of diverse users in the design process, and incorporates multiple perspectives when collaborating on project development (P1).
We have fully taken into account the needs of multiple consumers; both parents and hospital organizations have been carefully catered toward. Specifically, the individual biomimicry features of our incubator not only separates us from our competition, but also offers something new to our consumers. We understand that this product can be used to save hundreds of thousands of babies in developing countries, so we have specifically priced the product to hit this niche of customers. By offering a high quality product to a disadvantaged audience at an affordable price point, we are able to translate this product to higher-end consumers such as elite hospitals. Our team's ability to empathize has allowed us to not only incorporate their needs into our design process but also leave an everlasting impact on the marketplace.
Parents and hospitals are who we are marketing this product towards because hospitals will need medical staff to know how to customize the biomimicry in accordance to each individual babies needs. Hospitals need this technology since their current system in the NICU doesn’t cut it for certain babies and does not allow all of the developmental opportunities while outsider of the womb that our product does.
This also introduces something new to the market because the current products only address one developmental difficulty of babies with NAS, while our product will address many different difficulties, including heart, lung, temperature, and light regulation to be as close as possible to the conditions of the womb.
We are targeting this product at third world countries because of the affordable cost and because they don't have the care they need. In addition, we will be able to recognize needs of the baby by analyzing the data either locally or by communicating globally. We could also get them in contact with hospitals to help them customize the needs of the baby according to their certain conditions.
One example of a location in the U.S. where this can be most effective is in West Virginia. It has some of the most quickly increasing rates of opioid abuse and NAS rates in the country. Matthew Grossman, a neonatologist at Yale, suggested to us in an interview two market this toward West Virginia because of the growing rates of NAS.
We have fully taken into account the needs of multiple consumers; both parents and hospital organizations have been carefully catered toward. Specifically, the individual biomimicry features of our incubator not only separates us from our competition, but also offers something new to our consumers. We understand that this product can be used to save hundreds of thousands of babies in developing countries, so we have specifically priced the product to hit this niche of customers. By offering a high quality product to a disadvantaged audience at an affordable price point, we are able to translate this product to higher-end consumers such as elite hospitals. Our team's ability to empathize has allowed us to not only incorporate their needs into our design process but also leave an everlasting impact on the marketplace.
Parents and hospitals are who we are marketing this product towards because hospitals will need medical staff to know how to customize the biomimicry in accordance to each individual babies needs. Hospitals need this technology since their current system in the NICU doesn’t cut it for certain babies and does not allow all of the developmental opportunities while outsider of the womb that our product does.
This also introduces something new to the market because the current products only address one developmental difficulty of babies with NAS, while our product will address many different difficulties, including heart, lung, temperature, and light regulation to be as close as possible to the conditions of the womb.
We are targeting this product at third world countries because of the affordable cost and because they don't have the care they need. In addition, we will be able to recognize needs of the baby by analyzing the data either locally or by communicating globally. We could also get them in contact with hospitals to help them customize the needs of the baby according to their certain conditions.
One example of a location in the U.S. where this can be most effective is in West Virginia. It has some of the most quickly increasing rates of opioid abuse and NAS rates in the country. Matthew Grossman, a neonatologist at Yale, suggested to us in an interview two market this toward West Virginia because of the growing rates of NAS.